Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19
Introduction: The ongoing pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed important challenges for clinicians and health-care systems worldwide.Areas covered: The aim of this manuscript is to provide brief guidance for intensive care unit management of mechanically ventilated patients with COVID-19 based on the literature and our direct experience with this population. PubMed, EBSCO, and the Cochrane Library were searched up until 15th of January 2021 for relevant literature.Expert opinion: Initially, the respiratory management of COVID-19 relied on the general therapeutic principles for acute respiratory distress syndrome; however, recent findings have suggested that the pathophysiology of hypoxemia in patients with COVID-19 presents specific features and changes over time. Several therapies, including antiviral and anti-inflammatory agents, have been proposed recently. The optimal intensive care unit management of patients with COVID-19 remains unclear; therefore, ongoing and future clinical trials are warranted to clarify the optimal strategies to adopt in this cohort of patients.
| Media Type: |
Electronic Article |
|---|
| Year of Publication: |
2021 |
|---|
| Contained In: |
Expert review of respiratory medicine - (06.04.2021), p. 1-10 |
|---|
| Language: |
English |
|---|
| Contributors: |
Robba, Chiara |
|---|
| Links: |
|---|
| Keywords: |
Antibiotic therapy |
|---|
| Notes: |
Date Revised 14.04.2021 published: Print-Electronic Citation Status Publisher Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine |
|---|
| Physical Description: |
Online-Ressource |
|---|
| doi: |
10.1080/17476348.2021.1906226 |
|---|---|
| PMID: |
33734900 |
| PPN (Catalogue-ID): |
NLM323997406 |
|---|
| LEADER | 02906nma a2200517 c 4500 | ||
|---|---|---|---|
| 001 | NLM323997406 | ||
| 003 | DE-601 | ||
| 005 | 20210414213854.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210319s2021 000 0 eng d | ||
| 024 | 7 | |a 10.1080/17476348.2021.1906226 |2 doi | |
| 028 | 5 | 2 | |a pubmed21n1231.xml |
| 035 | |a (DE-599)NLM33734900 | ||
| 040 | |b ger |c GBVCP | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Robba, Chiara | |
| 245 | 1 | 0 | |a Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19 |h Elektronische Ressource |
| 300 | |a Online-Ressource | ||
| 500 | |a Date Revised 14.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 500 | |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine | ||
| 520 | |a Introduction: The ongoing pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed important challenges for clinicians and health-care systems worldwide.Areas covered: The aim of this manuscript is to provide brief guidance for intensive care unit management of mechanically ventilated patients with COVID-19 based on the literature and our direct experience with this population. PubMed, EBSCO, and the Cochrane Library were searched up until 15th of January 2021 for relevant literature.Expert opinion: Initially, the respiratory management of COVID-19 relied on the general therapeutic principles for acute respiratory distress syndrome; however, recent findings have suggested that the pathophysiology of hypoxemia in patients with COVID-19 presents specific features and changes over time. Several therapies, including antiviral and anti-inflammatory agents, have been proposed recently. The optimal intensive care unit management of patients with COVID-19 remains unclear; therefore, ongoing and future clinical trials are warranted to clarify the optimal strategies to adopt in this cohort of patients | ||
| 611 | 2 | 7 | |a Journal Article |2 gnd |
| 655 | 7 | |a Severe acute respiratory syndrome coronavirus-2 |2 gnd | |
| 655 | 7 | |a antibiotic therapy |2 gnd | |
| 655 | 7 | |a anticoagulation |2 gnd | |
| 655 | 7 | |a corticosteroids |2 gnd | |
| 655 | 7 | |a mechanical ventilation |2 gnd | |
| 689 | 0 | 0 | |A f |a Journal Article |
| 689 | 0 | |5 DE-601 | |
| 689 | 1 | 0 | |a Severe acute respiratory syndrome coronavirus-2 |
| 689 | 1 | 1 | |a antibiotic therapy |
| 689 | 1 | 2 | |a anticoagulation |
| 689 | 1 | 3 | |a corticosteroids |
| 689 | 1 | 4 | |a mechanical ventilation |
| 689 | 1 | |5 DE-601 | |
| 700 | 1 | |a Battaglini, Denise | |
| 700 | 1 | |a Ball, Lorenzo | |
| 700 | 1 | |a Pelosi, Paolo | |
| 700 | 1 | |a Rocco, Patricia R M | |
| 773 | 0 | 8 | |i in |t Expert review of respiratory medicine |g (06.04.2021), p. 1-10 |q <1-10 |w (DE-601)NLM190769181 |x 1747-6356 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1080/17476348.2021.1906226 |3 Volltext |
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 06 |c 04 |h 1-10 | ||